COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS (RSV) PREVENTION INTERVENTIONS IN CHILDREN: A MODEL COMPARISON STUDY

被引：0
|
作者：
Li, X. X. [1 ]
Hodgson, D. [2 ]
Flaig, J. [3 ]
Kieffer, A. [4 ]
Herring, W. [5 ]
Beyhaghi, H. [6 ]
Williem, L. [1 ]
Jit, M. [2 ]
Bilcke, J. [1 ]
Beutels, P. [1 ]
机构：
[1] Univ Antwerp, Antwerp, Van, Belgium
[2] London Sch Hyg & Trop Med, London, England
[3] Epidemiol & Modeling Infect Dis EPIMOD, Lyon, France
[4] Sanofi, Lyon, France
[5] RTI Hlth Solut, Res Triangle Pk, NC USA
[6] Novavax Inc, Durham, NC USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE622
引用
收藏
页码：S178 / S178
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness of Respiratory Syncytial Virus Preventive Interventions in Children: A Model Comparison Study
    Li, Xiao
    Hodgson, David
    Flaig, Julien
    Kieffer, Alexia
    Herring, William L.
    Beyhaghi, Hadi
    Willem, Lander
    Jit, Mark
    Bilcke, Joke
    Beutels, Philippe
    VALUE IN HEALTH, 2023, 26 (04) : 508 - 518
  • [2] Pricey or priceless: cost-effectiveness of respiratory syncytial virus (RSV) prevention in infants
    Li, Xiao
    Bilcke, Joke
    Beutels, Philippe
    LANCET REGIONAL HEALTH-AMERICAS, 2024, 29
  • [3] COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINATION OF DUTCH ELDERLY
    Pouwels, K.
    Meijboom, M.
    Luytjes, W.
    Hak, E.
    Postma, M.
    VALUE IN HEALTH, 2011, 14 (07) : A271 - A271
  • [4] Evaluation of the potential impact and cost-effectiveness of respiratory syncytial virus (RSV) prevention strategies for infants in Argentina
    Guinazu, Gonzalo
    Dvorkin, Julia
    Mahmud, Sarwat
    Baral, Ranju
    Pecenka, Clint
    Libster, Romina
    Clark, Andrew
    Caballero, Mauricio T.
    VACCINE, 2024, 42 (23)
  • [5] A COST-EFFECTIVENESS ANALYSIS OF RESPIRATORY SYNCYTIAL VIRUS (RSV) PROPHYLAXIS IN INFANTS IN THE UK
    Bentley, A.
    Filipovic, I.
    Gooch, K.
    Buesch, K.
    THORAX, 2011, 66 : A136 - A137
  • [6] Cost-effectiveness of respiratory syncytial virus (RSV) prophylaxis among preterm infants in Poland
    Kowalik, E
    Jakubczyk, MK
    Niewada, MP
    Kamiñski, B
    VALUE IN HEALTH, 2003, 6 (06) : 758 - 759
  • [7] A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom
    Bentley A.
    Filipovic I.
    Gooch K.
    Büsch K.
    Health Economics Review, 3 (1) : 1 - 12
  • [8] Impact and cost-effectiveness of strategies to prevent respiratory syncytial virus (RSV) disease in Vietnam: A modelling study
    Do, Lien Anh Ha
    Le, Nguyen Thanh Nhan
    Mahmud, Sarwat
    Mulholland, Kim
    Pecenka, Clint
    Clark, Andrew
    VACCINE, 2023, 41 (46) : 6782 - 6790
  • [9] COST-EFFECTIVENESS OF PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION (RSV) WITH PALIVIZUMAB IN PRETERM INFANTS IN COLOMBIA
    Rosselli, D.
    Rueda, J. D.
    Ruiz, J. G.
    VALUE IN HEALTH, 2013, 16 (03) : A75 - A75
  • [10] COST-EFFECTIVENESS ANALYSIS OF PALIVIZUMAB WITH RISK FACTORS FOR RESPIRATORY SYNCYTIAL VIRUS PREVENTION
    Lee, M. Y.
    Lee, E. K.
    VALUE IN HEALTH, 2012, 15 (07) : A398 - A398
12345